Skip to search.
 TSX Down 2.02% TSX Ventures Down 0.54%

More On AZN

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

AstraZeneca PLC (AZN)

-NYSE
28.59 Down 0.10(0.35%) 4:02PM EST
|After Hours : 28.27 Down 0.32 (1.12%) 5:17PM EST
Prev Close:28.69
Open:28.32
Bid:28.30 x 300
Ask:29.99 x 100
1y Target Est:35.91
Beta:0.71793
Next Earnings Date:N/A
Day's Range:28.30 - 28.80
52wk Range:28.29 - 36.69
Volume:6,107,901
Avg Vol (3m):4,248,370
Market Cap:72.28B
P/E (ttm):25.64
EPS (ttm):1.12
Div & Yield:0.90 (3.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AZNDown 0.35%72.28B
GSKDown 0.33%95.20B
PFEUp 1.89%179.65B
MRKUp 0.68%137.33B

Key Statistics

Forward P/E (1 yr):10.32
P/S (ttm):2.94
Ex-Dividend Date:12-Aug-15

Analysts

Annual EPS Est (Dec-16) :2.08
Quarterly EPS Est (Mar-16) :1.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-13.79

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback